Recalls from Lannett Company Inc.

• Lannett Dextroamphetamine and Amphetamine Extended-Release Capsules (opens in a new tab)
  Moderate risk, FDA, Jul 2, 2026, Labeling error
• Lannett Niacin Extended-Release Tablets (opens in a new tab)
  Moderate risk, FDA, Jun 3, 2026, Drug dissolving problem
• Lannett Primidone Tablets (opens in a new tab)
  Low risk, FDA, May 18, 2026, Contamination

Data: Recall Canary (opens in a new tab)